Endoscopic ultrasound-guided fine-needle biopsy in patients with unexplained diffuse gastrointestinal wall thickening

Abstract

Background and study aims Endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) is recommended after non-diagnostic biopsy in gastrointestinal wall thickening, although the performance of currently available FNB needles in this setting is unknown. We aimed to assess the diagnostic accuracy and safety of EUS-FNB and to evaluate the "T" wall staging in malignant pathology.

Patients and methods This was a single center retrospective study that included all consecutive patients undergoing EUS-FNB for diffuse gastrointestinal wall thickening with at least one previous negative conventional endoscopic biopsy between January 2016 and November 2019. EUS-FNB was performed using linear-array echoendoscopes with slow-pull/fanning technique. Tissue acquisition was done with 19- or 22-gauge biopsy needles. Samples were included in formalin without rapid on-site evaluation and submitted for histopathological processing. The final diagnosis was based on conclusive histology or absence of evidence of disease progression after follow-up at least 6 months.

Results Twenty-nine patients (21 men), with a median age of 68 (IQR: 56–77), were included. EUS-FNB was technically feasible and the sample quality was adequate for full histological assessment in all patients (100 %). Sensitivity, specificity, positive and negative predictive values, and overall accuracy for diagnosis of malignancy were 95.5 %, 100 %, 100 %, 83.3 %, and 96.3 %, respectively. In patients with malignant disease, the samples obtained allowed detection of signs of deep layer infiltration (“histological staging”) in 17 of 21 cases (81 %). No adverse events were noted.

Conclusions The EUS-FNB technique demonstrated excellent diagnostic performance and safety in the study of unexplained diffuse gastrointestinal wall thickening. Histological staging was obtained in a high percentage of samples.

Publikationsverlauf

Eingereicht: 19. Mai 2020

Angenommen: 07. August 2020

Artikel online veröffentlicht:
16. September 2021

• References

• 1 Sharma V, Rana SS, Bhasin DK. Diffuse gastric wall thickening: appearances can be deceptive. Clin Gastroenterol Hepatol 2015; 13: e121-122
• 2 Kawano H, Ishii A, Kimura T. et al. IgG4-related disease manifesting the gastric wall thickening. Pathol Int 2016; 66: 23-28
• 3 Kwack WG, Ho WJ, Kim JH. et al. Understanding the diagnostic yield of current endoscopic biopsy for gastric neoplasm: A prospective single-center analysis based on tumor characteristics stratified by biopsy number and site. Medicine (Baltimore) 2016; 95: e4196
• 4 Lim H, Lee GH, Na HK. et al. Use of endoscopic ultrasound to evaluate large gastric folds: features predictive of malignancy. Ultrasound Med Biol 2015; 41: 2614-2620
• 5 Dumonceau JM, Deprez PH, Jenssen C. et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated January 2017. Endoscopy 2017; 49: 695-714
• 6 Aithal GP, Anagnostopoulos GK, Kaye P. EUS-guided Trucut mural biopsies in the investigation of unexplained thickening of the esophagogastric wall. Gastrointest Endosc 2005; 62: 624-629
• 7 Muraoka S, Tsuchida K, Iwasaki M. et al. A case report of gastric linitis plastica diagnosed by endoscopic ultrasound-guided fine needle aspiration. Medicine (Baltimore) 2017; 96: e8937
• 8 Iglesias-Garcia J, Abdulkader I, Larino-Noia J. et al. Evaluation of the adequacy and diagnostic accuracy of the histology samples obtained with a newly designed 19-gauge EUS histology needle. Rev Esp Enferm Dig 2014; 106: 6-14
• 9 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
• 10 Gines A, Pellise M, Fernandez-Esparrach G. et al. Endoscopic ultrasonography in patients with large gastric folds at endoscopy and biopsies negative for malignancy: predictors of malignant disease and clinical impact. Am J Gastroenterol 2006; 101: 64-69
• 11 Wiersema MJ, Vilmann P, Giovannini M. et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997; 112: 1087-1095
• 12 Vander Noot 3rd. MR, Eloubeidi MA, Chen VK. et al. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2004; 102: 157-163
• 13 Pellise Urquiza M, Fernandez-Esparrach G, Sole M. et al. Endoscopic ultrasound-guided fine needle aspiration: predictive factors of accurate diagnosis and cost-minimization analysis of on-site pathologist. Gastroenterol Hepatol 2007; 30: 319-324
• 14 Tellez-Avila FI, Duarte-Medrano G, Lopez-Arce G. et al. EUS-guided tissue samples for the diagnosis of patients with a thickened gastric wall and prior negative endoscopic biopsies. Acta Gastroenterol Belg 2019; 82: 359-362
• 15 Yu L, Chen K, Xu Y. et al. The value of EUS in combination with cytological, flow cytometry, and gene rearrangement in the diagnosis of gastrointestinal lymphoma. Hematol Oncol 2017; 35: 303-309
• 16 Iglesias-Garcia J, Poley JW, Larghi A. et al. Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study. Gastrointest Endosc 2011; 73: 1189-1196
• 17 Larghi A, Verna EC, Ricci R. et al. EUS-guided fine-needle tissue acquisition by using a 19-gauge needle in a selected patient population: a prospective study. Gastrointest Endosc 2011; 74: 504-510
• 18 Lee YT, Ng EK, Hung LC. et al. Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut 2005; 54: 1541-1545
• 19 Early DS, Acosta RD. ASGE Standards of Practice Committee. et al. Adverse events associated with EUS and EUS with FNA. Gastrointest Endosc 2013; 77: 839-843